Non-Invasive Blood Glucose Monitoring Devices Market Growth Analysis Report, Forecast to 2027


The research report provides an in-depth analysis of the market and includes thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

Diabetes has evolved as a primary healthcare epidemic characterised by high blood sugar levels and a leading cause of death worldwide. In 2014, the World Health Organization (WHO) estimated that 8.5% of adults had diabetes. A diabetic cannot either synthesise enough insulin (type 1 diabetes) or does not produce enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes).

Gestational diabetes is a type of diabetes that occurs in pregnant women. However, gestational diabetes usually resolves after delivery but can lead to type 2 diabetes later in a woman's life. Most continuous glucose monitoring devices are invasive and involve the use of needles, which increases the risk of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose.

Certain signs of hyperglycemia between measurements, however, are not recorded, resulting in a distorted or non-existent representation of the blood glucose pattern. Noninvasive glucose monitoring eliminates the need for painful pricking, which increases the risk of infection and the amount of damage done to the finger tissue.

As a result, non-invasive continuous glucose monitoring devices have been widely investigated and studied in recent years for their ability to continuously monitor glucose under highly controlled (e.g., in-clinic) conditions. Near Infrared Spectroscopy (NIRS), Mid-Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT), and many other techniques are used to measure blood glucose levels non-invasively.

Request Brochure @ 
https://www.futuremarketinsights.com/reports/brochure/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Drivers & Restraints

The rising global prevalence of diabetes is expected to increase the use of noninvasive blood glucose monitoring devices among the general population. The market for noninvasive blood glucose monitoring devices is expected to grow at a faster rate during the forecast period, owing to the numerous disadvantages imposed by the use of invasive blood glucose monitors and the growing need to develop noninvasive glucose monitoring diagnostic techniques.

For example, in June 2015, researchers in the United Kingdom developed a blood glucose device that uses low-powered lasers to measure blood glucose levels on the skin's surface. A bench-top version of the system is also currently in clinical trials and could hit the market in the coming years.

The device is expected to take the form of a watch or bracelet that communicates with a mobile phone or tablet to display data. This would allow patients to continuously monitor their glucose levels without the need for an implant. Due to significant physical and chemical interference, currently available blood glucose measuring devices lack specificity and sensitivity.

Multivariate regression analyses are used in non-invasive glucose monitoring devices to convert optical signals to glucose concentration. As a result, the device should be designed in such a way that it allows for the accurate detection of blood glucose levels, which is necessary for optimum therapy and disease management.

Non- Invasive Blood Glucose Monitoring Devices Market: Overview

Diabetes' rising global prevalence has significant economic consequences for individuals' lives. Diabetes is estimated to affect 350 million people worldwide today. Thus, continuous monitoring of blood glucose levels is required in order to manage the ever-increasing prevalence of diabetes in the current population.

As a result, manufacturers are focusing on developing highly reliable diagnostic techniques that monitor individuals' blood glucose levels with greater accuracy, with the potential to improve glycemic control and patient well-being.

Noninvasive blood glucose monitors provide enormous opportunity for all device manufacturers, patients, and various healthcare providers around the world by integrating sensing elements, electronics, and a reliable power source in a single unit. Blood glucose regulatory approvals are being expedited.

Ask for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Region-wise Outlook

Non-Invasive Blood Glucose Monitoring Devices market is divided into seven key regions based on region presence: North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan, Middle East, and Africa.

The growing diabetic population in the United States is a major factor driving the increased adoption of noninvasive blood glucose monitoring systems. Diabetes is estimated to affect 29.1 million people in the United States, according to the Centers for Disease Control and Prevention. According to the data, adults with diabetes have a 50% higher risk of dying.

Furthermore, the growing demand for continuous non-invasive blood glucose diagnosis methods among patients is expected to drive up demand for noninvasive blood glucose monitoring systems globally. Diabetes is more prevalent in certain areas. such as Asia Pacific, North America and Western Europe. Presence of several pipeline blood glucose monitoring systems and their expected launch is expected to drive the market for noninvasive blood glucose devices over the forecast period.

Request Methodology @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Segmentation

Non- invasive blood glucose monitoring devices marketis segmented by technology, modality end user and geography:

By Technology

  • MIR/NIR (Mid/Near Infrared Spectroscopy)
  • Raman Spectroscopy
  • Occlusion Spectroscopy
  • Optical Coherence Tomography
  • Thermal Emission Spectroscopy
  • Photoacoustic Spectroscopy
  • Impedance/Dielectric Spectroscopy
  • Electromagnetic
  • Polarimetry
  • Fluorescence

By Modality

  • Wearable Blood Glucose Monitoring Systems
  • Non-wearable /Table top Blood Glucose Monitoring Systems

By End User

  • Hospitals
  • Home Care Settings
  • Clinics
  • December 2022
  • REP-GB-2613
  • Upcoming
  • Healthcare

 

About Future market insights

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.

Contact Information

Future market insights

Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A, Jumeirah Lakes Towers, Dubai,


United Arab Emirates
Phone :
View website

Published in

Business , Health

Published on

Feb 01, 2023

Social Links